-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of the State Food and Drug Administration showed that Sichuan Kelun Pharmaceutical Co.
, Ltd.
entered the stage of administrative approval for the Sildenafil Citrate Orally Disintegrating Tablets, which were reported as imitation Category 4
.
According to data from Minet.
com, the sales of sildenafil in China's urban brick-and-mortar pharmacies will exceed 2.
5 billion yuan in 2020, and it is expected to hit a new high in 2021
.
Since the beginning of this year, Kelun Pharmaceutical has approved 5 products for the market, of which 3 are the first in China
.
Sildenafil citrate was developed by Pfizer for the treatment of erectile dysfunction (ED)
.
According to data from Minet.
com, the sales of sildenafil in Chinese urban brick-and-mortar pharmacies have risen steadily in recent years, exceeding 2.
5 billion yuan in 2020
.
Among them, Baiyunshan Pharmaceutical Factory has the largest market share, followed by Pfizer
.
Source: New version database of Minet.
At present, sildenafil citrate tablets and sildenafil citrate oral disintegrating tablets are listed on the market, and sildenafil citrate tablets are listed by Baiyunshan Pharmaceutical 15 companies including the General Plant, Qilu Pharmaceuticals, Nanjing Hailing Pharmaceuticals of Yangzijiang Pharmaceutical Group have production approvals, and 8 companies including Changchun High-tech Pharmaceuticals of Amendment Pharmaceuticals Group, Jiangxi Pharmaceuticals Durenhe Pharmaceuticals, and Jinan Mingxin Pharmaceuticals are under review; For Sildenafil citrate orally disintegrating tablets, only Pfizer, the original researcher, has a production approval.
Seven companies including Jiangxi Shimei Pharmaceutical and Hebei Longhai Pharmaceutical are applying for production and review, while Sichuan Kelun Pharmaceutical has entered the stage of administrative approval.
, is expected to win the first imitation
.
Since the beginning of this year, Kelun Pharmaceutical has approved 5 products for the market, among which, Trilagliptin succinate tablets, medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion /amino acid (16)/glucose (36%) injection is the first in China
.
Source: State Food and Drug Administration official website, Minet database Note: Minet China's urban physical pharmacy terminal competition pattern database covers 297 cities and above nationwide physical pharmacies (excluding county and rural physical pharmacies), continuous monitoring of all categories An enlarged version of the city's brick-and-mortar pharmacy database
.
The above sales are calculated based on the average retail price of the product in the terminal
.
, Ltd.
entered the stage of administrative approval for the Sildenafil Citrate Orally Disintegrating Tablets, which were reported as imitation Category 4
.
According to data from Minet.
com, the sales of sildenafil in China's urban brick-and-mortar pharmacies will exceed 2.
5 billion yuan in 2020, and it is expected to hit a new high in 2021
.
Since the beginning of this year, Kelun Pharmaceutical has approved 5 products for the market, of which 3 are the first in China
.
Sildenafil citrate was developed by Pfizer for the treatment of erectile dysfunction (ED)
.
According to data from Minet.
com, the sales of sildenafil in Chinese urban brick-and-mortar pharmacies have risen steadily in recent years, exceeding 2.
5 billion yuan in 2020
.
Among them, Baiyunshan Pharmaceutical Factory has the largest market share, followed by Pfizer
.
Source: New version database of Minet.
At present, sildenafil citrate tablets and sildenafil citrate oral disintegrating tablets are listed on the market, and sildenafil citrate tablets are listed by Baiyunshan Pharmaceutical 15 companies including the General Plant, Qilu Pharmaceuticals, Nanjing Hailing Pharmaceuticals of Yangzijiang Pharmaceutical Group have production approvals, and 8 companies including Changchun High-tech Pharmaceuticals of Amendment Pharmaceuticals Group, Jiangxi Pharmaceuticals Durenhe Pharmaceuticals, and Jinan Mingxin Pharmaceuticals are under review; For Sildenafil citrate orally disintegrating tablets, only Pfizer, the original researcher, has a production approval.
Seven companies including Jiangxi Shimei Pharmaceutical and Hebei Longhai Pharmaceutical are applying for production and review, while Sichuan Kelun Pharmaceutical has entered the stage of administrative approval.
, is expected to win the first imitation
.
Since the beginning of this year, Kelun Pharmaceutical has approved 5 products for the market, among which, Trilagliptin succinate tablets, medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion /amino acid (16)/glucose (36%) injection is the first in China
.
Source: State Food and Drug Administration official website, Minet database Note: Minet China's urban physical pharmacy terminal competition pattern database covers 297 cities and above nationwide physical pharmacies (excluding county and rural physical pharmacies), continuous monitoring of all categories An enlarged version of the city's brick-and-mortar pharmacy database
.
The above sales are calculated based on the average retail price of the product in the terminal
.
